What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His main research concerns Renal cell carcinoma, Carcinoma, Surgery, Internal medicine and Nephrectomy.
His Renal cell carcinoma study combines topics from a wide range of disciplines, such as Cancer, Kidney disease and Urology.
His Carcinoma research integrates issues from Clinical trial, Adenocarcinoma, Natural history, Survival analysis and Risk factor.
Allan J. Pantuck combines subjects such as Prostate-specific antigen, Prostate and Prostate cancer with his study of Surgery.
His biological study deals with issues like Oncology, which deal with fields such as Univariate analysis.
Allan J. Pantuck interconnects Epidemiology, Predictive value of tests, Retrospective cohort study, Proportional hazards model and Prospective cohort study in the investigation of issues within Nephrectomy.
His most cited work include:
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy (1814 citations)
- THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA (733 citations)
- Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy (593 citations)
What are the main themes of his work throughout his whole career to date?
Allan J. Pantuck mainly investigates Renal cell carcinoma, Internal medicine, Oncology, Pathology and Nephrectomy.
His research in Renal cell carcinoma intersects with topics in Carcinoma, Surgery, Kidney disease and Urology.
The concepts of his Carcinoma study are interwoven with issues in Survival rate, Survival analysis and Performance status.
His is doing research in Nephrology, Cancer, Prostate cancer, Stage and Clear cell renal cell carcinoma, both of which are found in Internal medicine.
His Oncology study incorporates themes from Hazard ratio, Clinical trial and Immunotherapy.
His study with Nephrectomy involves better knowledge in Kidney.
He most often published in these fields:
- Renal cell carcinoma (49.58%)
- Internal medicine (46.65%)
- Oncology (31.80%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (46.65%)
- Renal cell carcinoma (49.58%)
- Oncology (31.80%)
In recent papers he was focusing on the following fields of study:
Allan J. Pantuck mostly deals with Internal medicine, Renal cell carcinoma, Oncology, Prostate cancer and Cancer.
Allan J. Pantuck focuses mostly in the field of Internal medicine, narrowing it down to matters related to Placebo and, in some cases, Gastroenterology, Randomized controlled trial and Survival rate.
The study incorporates disciplines such as Carcinoma and Nephrectomy in addition to Renal cell carcinoma.
His Nephrectomy research incorporates elements of Surgery and Clinical significance.
In the field of Oncology, his study on Kidney cancer overlaps with subjects such as TRAC.
His studies deal with areas such as Logistic regression, Proportional hazards model, Propensity score matching and Urology as well as Cancer.
Between 2016 and 2021, his most popular works were:
- Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results (70 citations)
- Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial (67 citations)
- Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma (64 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Allan J. Pantuck spends much of his time researching Internal medicine, Renal cell carcinoma, Oncology, Surgery and Urology.
His work deals with themes such as Placebo and Chromosome, which intersect with Internal medicine.
His study in Renal cell carcinoma is interdisciplinary in nature, drawing from both Adjuvant, Carcinoma, Proportional hazards model and Nephrectomy.
His study on Oncology also encompasses disciplines like
- Immunotherapy and related Bladder cancer, Kidney cancer and Stage,
- Therapeutic effect, Urothelial carcinoma, Dissection and Logistic regression most often made with reference to Urologic Oncology,
- Enzalutamide, which have a strong connection to Tolerability.
His study looks at the relationship between Surgery and fields such as Upper urinary tract, as well as how they intersect with chemical problems.
Allan J. Pantuck has included themes like Cancer and Adverse effect in his Urology study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
